Sermorelin vs. Ipamorelin vs. CJC-1295: A Research Comparison
Research Use Only. This article is for scientific and educational reference only. All products are sold for research purposes and are not intended for human or animal consumption.
Overview
Sermorelin, Ipamorelin, and CJC-1295 are the three most widely studied peptides for growth hormone secretagogue research. Despite often being grouped together, they have distinct mechanisms, receptor targets, pharmacokinetics, and GH pulse characteristics that make each uniquely suited to different research applications. This comparison provides a structured analysis to guide research protocol selection.
Mechanism Comparison
| Parameter | Sermorelin | Ipamorelin | CJC-1295 (no DAC) | |-----------|-----------|-----------|-------------------| | Receptor | GHRH receptor | GHSR-1a (ghrelin receptor) | GHRH receptor | | Class | GHRH analogue | GHRP (ghrelin mimetic) | GHRH analogue | | Natural ligand mimicry | Yes (GHRH 1-29) | No (synthetic ghrelin mimetic) | Yes (GHRH 1-29) | | Cortisol/prolactin elevation | Minimal | Minimal | Minimal | | Appetite stimulation | No | Minimal | No |
Sermorelin is a truncated analogue of endogenous GHRH (amino acids 1-29 of the 44-amino acid GHRH). It binds the GHRH receptor on pituitary somatotrophs, stimulating GH synthesis and release.
Ipamorelin is a synthetic pentapeptide that mimics ghrelin's action at the GHSR-1a receptor. It stimulates GH release through a completely different receptor and signaling pathway than Sermorelin or CJC-1295.
CJC-1295 (no DAC) is a modified GHRH analogue with amino acid substitutions that increase stability compared to native GHRH, while preserving the GHRH receptor binding mechanism. The "no DAC" designation distinguishes it from CJC-1295 with Drug Affinity Complex, which has a dramatically longer half-life.
Pharmacokinetics Comparison
| Parameter | Sermorelin | Ipamorelin | CJC-1295 (no DAC) | |-----------|-----------|-----------|-------------------| | Half-life | 10-20 minutes | 2 hours | 30 minutes | | GH pulse duration | Short, physiological | Moderate | Moderate | | Receptor desensitization | Minimal | Minimal | Minimal | | Binding mode | GHRH-R | GHSR-1a | GHRH-R |
GH Pulse Characteristics
The pattern of GH release differs significantly between these peptides:
Sermorelin: Produces short, physiological-amplitude GH pulses closely mimicking natural GHRH-driven GH secretion. The short half-life means GH pulses return to baseline quickly, preserving the natural pulsatile pattern.
Ipamorelin: Produces clean GH pulses with minimal cortisol or prolactin co-stimulation — the most selective GH secretagogue among the three. The 2-hour half-life produces somewhat broader GH pulses than Sermorelin.
CJC-1295 (no DAC): Produces GH pulses of intermediate duration. When combined with Ipamorelin (the most common research combination), the synergistic effect of GHRH-R + GHSR-1a co-stimulation produces substantially larger GH pulses than either compound alone.
Research Applications
Sermorelin: Best suited for research requiring close mimicry of physiological GHRH-driven GH secretion. Its short half-life and natural GHRH-R mechanism make it the most "physiological" option.
Ipamorelin: Best suited for research requiring selective GH stimulation without cortisol or prolactin confounders. Its ghrelin receptor mechanism provides a distinct pharmacological tool for dissecting GH secretion pathways.
CJC-1295 (no DAC): Best suited for combination research with Ipamorelin, where the GHRH-R + GHSR-1a synergy produces the largest and most sustained GH pulses.
Combination Research: CJC-1295 + Ipamorelin
The combination of CJC-1295 (no DAC) + Ipamorelin is the most studied GHRH/GHRP combination in research. The rationale:
- CJC-1295 activates GHRH receptors → primes somatotrophs
- Ipamorelin activates GHSR-1a → triggers GH release
- The two pathways act synergistically → GH pulse 3-5x larger than either alone
- Both peptides have minimal cortisol/prolactin effects → clean GH signal
Summary
Sermorelin, Ipamorelin, and CJC-1295 represent complementary rather than interchangeable research tools. Sermorelin provides the most physiological GHRH mimicry; Ipamorelin provides the most selective GH stimulation; CJC-1295 provides the optimal synergistic partner for Ipamorelin in combination protocols.
See Also: Ipamorelin + CJC-1295 Combination Research | Sermorelin Research Overview | GHRP-2 vs. GHRP-6 vs. Hexarelin Comparison
Was this article helpful?
Click a star to rate
All compounds referenced in this article are available as research-grade peptides, independently verified by Freedom Diagnostics.